Doyoumoney

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total cash and short-term investments +	247.22	370.53	546.22	640.15	614.79	612.62	436.05
Cash and cash equivalents	60.18	105.60	145.65	123.55	293.83	140.41	96.67
Short-term investments	187.04	264.93	400.58	516.60	320.97	472.21	339.38
Other current assets	13.72	9.07	8.46	11.14	11.49	4.93	4.21
Total current assets	260.94	379.59	554.69	651.30	626.29	617.55	440.26
Total non-current assets +	79.11	111.27	195.34	286.27	501.12	290.73	115.37
Property, plant and equipment, net				166.27	120.10	124.06	43.71
Goodwill
Intangible assets
Long-term investments	19.00	32.01	48.51	115.04	330.53	163.44	68.98
Other non-current assets
Total assets	340.05	490.86	750.03	937.56	1,127.41	908.28	555.63

Total current liabilities +	49.41	53.79	34.52	37.03	46.74	49.29	22.05
Accounts payable	2.89	5.37	4.82	3.92	3.21	9.40	2.84
Short-term debt		7.97	6.27	4.53	1.17	3.62	0.34
Current portion of long-term debt
Deferred revenue
Other current liabilities	46.52	40.45	23.43	28.58	37.37	30.18	14.35
Total non-current liabilities +	42.44	54.25	60.56	67.28	150.88	140.56	125.53
Long-term debt
Capital lease obligations	50.99	58.97	63.17	67.70	67.82	50.96	27.13
Other non-current liabilities	0.52	3.25	3.66	4.11	150.88	0.53
Total liabilities	91.85	108.04	95.08	104.31	197.62	189.84	147.58

Total stockholders' equity +	248.20	382.82	654.95	833.25	929.79	718.44	408.06
Common stock and paid-in capital	1,867.76	1,727.93	1,657.06	1,600.73	1,514.15	1,052.58	537.73
Retained earnings	-1,619.55	-1,345.11	-1,002.11	-767.48	-584.36	-334.14	-129.67
Common shares outstanding	17	13	13	12	12	12	12

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20
Total cash and short-term investments +	254.02	247.22	319.62	276.79	301.18	370.53	440.55	491.12	526.30	546.22	575.43	595.75	612.77	640.15	648.13	655.56	613.91	614.79	618.92	824.52	604.93	612.62	0.00	0.00	436.05
Cash and cash equivalents	90.77	60.18	123.58	98.80	120.33	105.60	100.30	133.42	125.65	145.65	286.21	224.37	109.43	123.55	116.31	205.74	222.60	293.83	393.50	564.44	244.37	140.41			-436.05
Short-term investments	163.25	187.04	196.05	177.99	180.85	264.93	340.25	357.70	400.65	400.58	289.22	371.38	503.34	516.60	531.82	449.83	391.32	320.97	225.42	260.08	360.56	472.21			872.10
Other current assets	13.28	13.72	8.58	5.42	8.00	9.07	9.50	8.71	7.87	8.46	11.42	10.66	11.63	11.14	11.61	11.21	11.79	11.49	12.23	10.32	4.80	4.93
Total current assets	267.30	260.94	328.20	282.21	309.18	379.59	450.05	499.82	534.16	554.69	586.85	606.41	624.40	651.30	659.75	666.78	625.71	626.29	631.15	834.84	609.74	617.55			436.05
Total non-current assets +	83.32	79.11	79.76	103.24	120.62	111.27	169.17	154.32	160.06	195.34	208.14	228.94	256.05	286.27	317.52	354.90	446.40	501.12	567.19	395.03	267.45	290.73			-436.05
Property, plant and equipment, net												113.68	118.60	166.27	125.73	127.56	125.71	120.10	115.86	158.06	144.87
Goodwill
Intangible assets
Long-term investments	25.95	19.00	19.00	39.06	47.95	32.01	39.11	19.00	19.00	48.51	54.73	68.95	90.18	115.04	144.52	178.44	271.12	330.53	400.96	233.71	118.65	163.44
Other non-current assets
Total assets	350.63	340.05	407.97	385.45	429.80	490.86	619.22	654.14	694.22	750.03	794.99	835.35	880.45	937.56	977.27	1,021.67	1,072.10	1,127.41	1,198.33	1,229.87	877.19	908.28

Total current liabilities +	36.95	49.41	31.88	36.90	41.29	53.79	33.51	30.88	32.35	34.52	35.06	34.39	30.80	37.03	51.22	50.29	41.06	46.74	59.28	63.66	56.81	49.29
Accounts payable	5.47	2.89	2.57	3.38	3.73	5.37	3.60	4.20	4.90	4.82	4.37	5.81	5.73	3.92	4.80	4.25	6.51	3.21	3.53	4.86	7.12	9.40
Short-term debt				8.51	8.24	7.97	7.13	6.90	6.67	6.27	6.06	5.85	4.81	4.53		21.40		1.17	25.06	25.57	26.04	3.62
Current portion of long-term debt
Deferred revenue
Other current liabilities	31.48	46.52	29.31	25.01	29.32	40.45	22.78	19.78	20.79	23.43	24.64	22.73	20.25	28.58	35.23	30.62	28.32	37.37	50.17	50.57	41.78	30.18
Total non-current liabilities +	40.01	42.44	46.97	49.63	51.99	54.25	55.01	56.76	58.71	60.56	62.35	64.11	65.83	67.28	106.03	103.34	149.80	150.88	152.58	144.25	143.46	140.56
Long-term debt
Capital lease obligations	39.49	50.99	44.29	46.60	48.85	58.97	51.44	53.32	55.16	63.17	58.58	60.22	61.83	67.70	64.64	66.07	67.48	67.82	65.68	61.47	57.76	54.57
Other non-current liabilities	0.53	0.52	2.68	3.03	3.14	3.25	3.57	3.44	3.55	3.66	3.78	64.11	65.83	4.11	106.03	103.34	149.80	150.88	152.58	0.90	0.89	0.53
Total liabilities	76.96	91.85	78.84	86.53	93.28	108.04	88.52	87.64	91.06	95.08	97.42	98.50	96.62	104.31	157.24	153.63	190.85	197.62	211.86	207.91	200.27	189.84

Total stockholders' equity +	273.67	248.20	329.12	298.92	336.52	382.82	530.70	566.50	603.16	654.95	697.57	736.86	783.83	833.25	820.03	868.04	881.25	929.79	986.47	1,021.96	676.92	718.44			408.06
Common stock and paid-in capital	1,917.37	1,867.76	1,807.95	1,738.91	1,733.82	1,727.93	1,683.87	1,675.09	1,665.94	1,657.06	1,646.76	1,635.18	1,618.27	1,600.73	1,579.11	1,556.87	1,533.76	1,514.15	1,487.13	1,473.74	1,066.11	1,052.58	0.00	0.00	408.06
Retained earnings	-1,643.71	-1,619.55	-1,478.83	-1,439.99	-1,397.30	-1,345.11	-1,153.17	-1,108.59	-1,062.78	-1,002.11	-949.18	-898.33	-834.44	-767.48	-759.08	-688.83	-652.51	-584.36	-500.66	-451.78	-389.19	-334.14
Common shares outstanding	22	17	18	15	15	13	13	13	13	13	13	13	12	12	12	12	12	12	12	12	12	12	12	12	12

Balance Sheet - Lyell Immunopharma, Inc. (LYEL)

Balance Sheet - Lyell Immunopharma, Inc. (LYEL)